BioPorto logo


BioPorto A/S is a global biotech company that specializes in the development and manufacturing of in-vitro diagnostic tests and antibodies for both research and clinical applications. The company's diagnostics products are primarily based on a patented proprietary technology platform called MoAb®. The Company's products are used in research, including preclinical studies and clinical trials, as well as in diagnosis procedures to detect infectious diseases, cancer, autoimmune disorders and other diseases. BioPorto A/S is based in Hellerup, Denmark.

Latest events on Quartr

Previous Events for BioPorto





About the company

Investor Relations page

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot